Medipost Co (XKRX:078160) Price-to-Operating-Cash-Flow : (As of Apr. 30, 2024)

View and export this data going back to 2005. Start your Free Trial

What is Medipost Co Price-to-Operating-Cash-Flow?

As of today (2024-04-30), Medipost Co's share price is ₩7070.00. Medipost Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-844.54. Hence, Medipost Co's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Medipost Co's Price-to-Operating-Cash-Flow or its related term are showing as below:

During the past 13 years, Medipost Co's highest Price-to-Operating-Cash-Flow Ratio was 2849.55. The lowest was 44.65. And the median was 91.01.

XKRX:078160's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 24.83
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Medipost Co's Cash Flow from Operations per share for the three months ended in Dec. 2023 was ₩-195.79. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-844.54.

During the past 13 years, Medipost Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 4.60% per year. The lowest was -74.20% per year. And the median was -19.90% per year.

Medipost Co Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Medipost Co's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medipost Co Price-to-Operating-Cash-Flow Chart

Medipost Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

72.20

301.26

83.83

Medipost Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Medipost Co's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Medipost Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medipost Co's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Medipost Co's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Medipost Co's Price-to-Operating-Cash-Flow falls into.

Medipost Co Price-to-Operating-Cash-Flow Calculation

Medipost Co's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	7070.00	/	-844.538
	=

Medipost Co's Share Price of today is ₩7070.00.
Medipost Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-844.54.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Medipost Co Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Medipost Co's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Medipost Co (XKRX:078160) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medipost Co Ltd (XKRX:078160) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

N/A

Address

21, Daewangpangyo-ro 644, Bundang-gu, Gyeonggi-do, Seongnam, KOR

Website

http://www.medi-post.co.kr

Medipost Co Ltd is a Korea-based stem cell biotechnology company. The company is engaged in developing products to meet unmet medical needs. The company operates its business through four distinct segments: Stem Cell Therapeutics, Cord Blood Bank, Cosmetics, and Health Supplements. The Cord Blood Bank Division is involved in collecting and storing stem cells from the newborn's umbilical cord. The Stem Cell Therapeutics division manufactures allogeneic stem cell drug products. The Health Supplements division offers vitamins and nutritional supplements. The Cosmetics division is involved in the sales and marketing of natural cosmetics.

Medipost Co (XKRX:078160) Headlines

No Headlines